Jacqueline Tebeest
Family · Blue Springs, MONPI 1831591684
Payments from drug & device makers
Across 79 payments — averaging $17.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$341
- Pfizer$109
- Lilly USA, LLC$103
- Novo Nordisk$102
- Novartis$93
- Amgen$63
- plus $557 from 19 others
What the payments were for
- Food & beverage$1,368100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 19 | $341 |
| Pfizer | 7 | $109 |
| Lilly USA, LLC | 6 | $103 |
| Novo Nordisk | 6 | $102 |
| Novartis | 6 | $93 |
| Amgen | 4 | $63 |
| Abbott | 3 | $62 |
| AstraZeneca | 4 | $61 |
| Merck | 3 | $52 |
| Bayer | 2 | $36 |
| Esperion Therapeutics, Inc. | 2 | $35 |
| Teva Pharmaceuticals USA, Inc. | 2 | $34 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $32 |
| Astellas Pharma US Inc | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Mannkind Corporation | 1 | $24 |
| Corcept Therapeutics | 1 | $23 |
| Ascensia Diabetes Care US Inc. | 1 | $20 |
| Philips North America LLC | 1 | $20 |
| Insulet Corporation | 1 | $20 |
| Ironwood Pharmaceuticals, Inc | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Viatris Specialty LLC | 1 | $16 |
| Exact Sciences | 1 | $15 |
| Electromed, Inc. | 1 | $14 |
How this compares
$1,368 in reported general payments places this provider in the 70th percentile of 3,812 family providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 20 | $24,197 |
| JardianceEmpagliflozin | 12 | $13,630 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $5,020 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 37 | $780 |
| Levothyroxine Sodium | 82 | $374 |
| Rosuvastatin Calcium | 52 | $367 |
| Gabapentin | 22 | $358 |
| Losartan Potassium | 36 | $349 |
| Tizanidine Hcl | 40 | $349 |
| Lisinopril | 63 | $338 |
| Atorvastatin Calcium | 69 | $321 |
| Omeprazole | 23 | $289 |
| Amlodipine Besylate | 59 | $272 |
| Pantoprazole Sodium | 34 | $254 |
| Potassium Chloride | 27 | $252 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $103 | $24,19720 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,812 family providers in Missouri.
Other family in Blue Springs
- Erica GormanBlue Springs$14K
- Connie SpencerSaint Joseph$320K
- Shayla SandersKansas City$306K
- Tamera WolfLees Summit$215K
- Tiffany ArnoldFestus$177K
- Tiffany NelsonSedalia$164K
- Chelsey BeckerSaint Peters$104K
- Carey PattonDes Peres$94K
- Marcy MarkesColumbia$92K
- Laura HedigerSpringfield$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.